Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.

Hugh Andrew Jinwook KimPeter Y F ZengAlana SorginiMushfiq H ShaikhHalema KhanS Danielle MacNeilMohammed I KhanAdrian MendezJohn YooKevin FungPencilla LangDavid A PalmaJoe S MymrykJohn W BarrettKrupal B PatelPaul C BoutrosAnthony Charles Nichols

Published in: Head & neck (2022)

There are molecular differences between tumors of Black and White patients that may partially account for differences in survival. These may inform targeted treatment decisions to achieve equitable outcomes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
type diabetes
cancer therapy
patient reported outcomes
metabolic syndrome
drug delivery
skeletal muscle